Population Pharmacokinetics of Sarafloxacin in Yellow River Carp (Cyprinus carpio Haematopterus) After One Single Oral Dose.

IF 1.7 4区 农林科学 Q3 PHARMACOLOGY & PHARMACY
Yue Liu, Fang Yang, Yang-Guang Jin, Yan-Ni Zhang, Long-Ji Sun, Shi-Hao Li, Yu-Xin Chen, Wen-Rui Wang, Fan Yang
{"title":"Population Pharmacokinetics of Sarafloxacin in Yellow River Carp (Cyprinus carpio Haematopterus) After One Single Oral Dose.","authors":"Yue Liu, Fang Yang, Yang-Guang Jin, Yan-Ni Zhang, Long-Ji Sun, Shi-Hao Li, Yu-Xin Chen, Wen-Rui Wang, Fan Yang","doi":"10.1111/jvp.70021","DOIUrl":null,"url":null,"abstract":"<p><p>The objective of this study was to investigate the population pharmacokinetics of sarafloxacin following a single oral administration at a dose of 20 mg/kg body weight (BW) in Yellow River carp (Cyprinus carpio haematopterus) reared at 24°C, and to provide a scientific basis for its rational use in aquaculture. Blood samples were collected from the tail vein of six fish at each predetermined time point: 0.25, 0.5, 1, 2, 4, 6, 8, 12, 16, 24, 36, 46, 48, 92, 96, 120, and 144 h post-administration, using a sparse sampling design. Blood was collected only four times per fish, and six fish were sampled at each time point. Plasma concentrations of sarafloxacin were measured using high-performance liquid chromatography (HPLC), and the drug remained quantifiable in plasma up to 120 h post-administration. Population pharmacokinetic modeling was conducted using nonlinear mixed-effects modeling to characterize both the typical population parameters (fixed effects) and inter-individual variability (random effects). Covariate and covariance models were incorporated to account for variability and improve model predictability under sparse sampling conditions. The final population model estimated typical values (tv) and inter-individual coefficients of variation (CV%) for the absorption rate constant (tvK<sub>a</sub>), apparent volume of distribution (tvV), and clearance (tvCL) as 14.889 h<sup>-1</sup> (CV: 3.04%), 31.573 L/kg (CV: 0.39%), and 2.885 L/h/kg (CV: 0.38%), respectively. Based on the calculated AUC/MIC or C<sub>max</sub>/MIC ratios, the current oral dosing regimen of 20 mg/kg BW appears to be effective against pathogens with MIC values below 0.05 μg/mL.</p>","PeriodicalId":17596,"journal":{"name":"Journal of veterinary pharmacology and therapeutics","volume":" ","pages":""},"PeriodicalIF":1.7000,"publicationDate":"2025-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of veterinary pharmacology and therapeutics","FirstCategoryId":"97","ListUrlMain":"https://doi.org/10.1111/jvp.70021","RegionNum":4,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

The objective of this study was to investigate the population pharmacokinetics of sarafloxacin following a single oral administration at a dose of 20 mg/kg body weight (BW) in Yellow River carp (Cyprinus carpio haematopterus) reared at 24°C, and to provide a scientific basis for its rational use in aquaculture. Blood samples were collected from the tail vein of six fish at each predetermined time point: 0.25, 0.5, 1, 2, 4, 6, 8, 12, 16, 24, 36, 46, 48, 92, 96, 120, and 144 h post-administration, using a sparse sampling design. Blood was collected only four times per fish, and six fish were sampled at each time point. Plasma concentrations of sarafloxacin were measured using high-performance liquid chromatography (HPLC), and the drug remained quantifiable in plasma up to 120 h post-administration. Population pharmacokinetic modeling was conducted using nonlinear mixed-effects modeling to characterize both the typical population parameters (fixed effects) and inter-individual variability (random effects). Covariate and covariance models were incorporated to account for variability and improve model predictability under sparse sampling conditions. The final population model estimated typical values (tv) and inter-individual coefficients of variation (CV%) for the absorption rate constant (tvKa), apparent volume of distribution (tvV), and clearance (tvCL) as 14.889 h-1 (CV: 3.04%), 31.573 L/kg (CV: 0.39%), and 2.885 L/h/kg (CV: 0.38%), respectively. Based on the calculated AUC/MIC or Cmax/MIC ratios, the current oral dosing regimen of 20 mg/kg BW appears to be effective against pathogens with MIC values below 0.05 μg/mL.

单次口服萨拉沙星在黄河鲤鱼体内的种群药动学
本试验旨在研究色拉沙星单次口服剂量为20 mg/kg体重(BW)在24℃饲养的黄河鲤鱼(Cyprinus carpio haematopterus)体内的药代动力学,为其在水产养殖中的合理使用提供科学依据。采用稀疏抽样设计,在给药后0.25、0.5、1、2、4、6、8、12、16、24、36、46、48、92、96、120和144 h的每个预定时间点从6条鱼的尾静脉采集血液。每条鱼只采集4次血液,每个时间点采集6条鱼。使用高效液相色谱(HPLC)测定血浆中萨拉沙星的浓度,药物在给药后120小时仍可在血浆中定量。群体药代动力学建模采用非线性混合效应建模来表征典型群体参数(固定效应)和个体间变异性(随机效应)。协变量和协方差模型被纳入到稀疏采样条件下的可变性和提高模型的可预测性。最终种群模型估计的吸收率常数(tvKa)、表观分布容积(tvV)和清除率(tvCL)的典型值(tv)和个体间变异系数(CV%)分别为14.889 h-1 (CV: 3.04%)、31.573 L/kg (CV: 0.39%)和2.885 L/h/kg (CV: 0.38%)。根据计算的AUC/MIC或Cmax/MIC比值,目前口服剂量为20 mg/kg BW的方案似乎对MIC值低于0.05 μg/mL的病原体有效。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.10
自引率
15.40%
发文量
69
审稿时长
8-16 weeks
期刊介绍: The Journal of Veterinary Pharmacology and Therapeutics (JVPT) is an international journal devoted to the publication of scientific papers in the basic and clinical aspects of veterinary pharmacology and toxicology, whether the study is in vitro, in vivo, ex vivo or in silico. The Journal is a forum for recent scientific information and developments in the discipline of veterinary pharmacology, including toxicology and therapeutics. Studies that are entirely in vitro will not be considered within the scope of JVPT unless the study has direct relevance to the use of the drug (including toxicants and feed additives) in veterinary species, or that it can be clearly demonstrated that a similar outcome would be expected in vivo. These studies should consider approved or widely used veterinary drugs and/or drugs with broad applicability to veterinary species.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信